Skip to main content
# Title Department Research Year
2501 A highly sensitive enzyme immunoassay for evaluation of 2_-deoxycytidine plasma level as a prognostic marker for breast cancer chemotherapy Department of Pharmaceutical Analytical Chemistry 2009
2502 The trichloroethyl group as a protecting group for sulfonates and its application to the synthesis of a disulfonate analog of the tyrosine sulfated PSGL-1143−50 peptide Department of Medicinal Chemistry 2009
2503 ANTIFOULING ALKALOIDS FROM CRINUM AUGUSTUM (AMARYLLIDACEAE).
Department of Pharmacognosy 2009
2504 Formulation of ketorlac tromethamine in semi-solid dosage forms. Department of Pharmaceutics 2009
2505 Iron-Mediated Cleavage of C-C Bonds in Vicinal Tricarbonyl Compounds in Water Department of Pharmacognosy 2009
2506 Quantitative Structure-Activity Relationship (QSAR) Studies
on a Series of 1,3,4-thiadiazole-2-thione Derivatives as
Tumor-Associated Carbonic Anhydrase IX Inhibitors
Department of Medicinal Chemistry 2009
2507 Preparation, Antimicrobial and Estrogenic Activity of Ferutinin and Selected Analogs. Department of Medicinal Chemistry 2009
2508 Formulation and Evaluation of Rofecoxib Capsules, Saudi Journal of Pharmaceutical Sciences, Vol. 17, No. 1, January (2009). Department of Industrial Pharmacy 2009
2509 Small-Sized Human Immunodeficiency Virus Type-1
Protease Inhibitors Containing Allophenylnorstatine to
Explore the S2' Pocket
Department of Medicinal Chemistry 2009
2510 The Proteolytic Stability and Cytotoxicity Studies of l‐Aspartic Acid and l‐Diaminopropionic Acid derived β‐Peptides and a Mixed α/β‐Peptide Department of Medicinal Chemistry 2009